SCA
ABMD
Snowden Capital Advisors’s Abiomed Inc ABMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,725
| Closed | -$423K | – | 1181 |
|
2022
Q3 | $423K | Buy |
1,725
+5
| +0.3% | +$1.23K | 0.02% | 719 |
|
2022
Q2 | $425K | Buy |
1,720
+11
| +0.6% | +$2.72K | 0.02% | 696 |
|
2022
Q1 | $566K | Buy |
1,709
+1,010
| +144% | +$335K | 0.02% | 589 |
|
2021
Q4 | $251K | Sell |
699
-27
| -4% | -$9.7K | 0.01% | 618 |
|
2021
Q3 | $236K | Sell |
726
-908
| -56% | -$296K | 0.01% | 781 |
|
2021
Q2 | $510K | Sell |
1,634
-1,728
| -51% | -$539K | 0.03% | 543 |
|
2021
Q1 | $1.07M | Sell |
3,362
-283
| -8% | -$90.2K | 0.06% | 326 |
|
2020
Q4 | $1.18M | Buy |
3,645
+3
| +0.1% | +$973 | 0.08% | 285 |
|
2020
Q3 | $1.01M | Sell |
3,642
-88
| -2% | -$24.4K | 0.08% | 267 |
|
2020
Q2 | $901K | Sell |
3,730
-2,567
| -41% | -$620K | 0.08% | 276 |
|
2020
Q1 | $914K | Sell |
6,297
-685
| -10% | -$99.4K | 0.1% | 253 |
|
2019
Q4 | $1.19M | Sell |
6,982
-4,229
| -38% | -$721K | 0.11% | 252 |
|
2019
Q3 | $1.99M | Buy |
11,211
+66
| +0.6% | +$11.7K | 0.2% | 158 |
|
2019
Q2 | $2.9M | Buy |
11,145
+60
| +0.5% | +$15.6K | 0.3% | 113 |
|
2019
Q1 | $3.17M | Sell |
11,085
-11,272
| -50% | -$3.22M | 0.35% | 87 |
|
2018
Q4 | $7.27M | Sell |
22,357
-562
| -2% | -$183K | 0.94% | 10 |
|
2018
Q3 | $10.3M | Buy |
22,919
+39
| +0.2% | +$17.5K | 1.17% | 5 |
|
2018
Q2 | $9.36M | Buy |
+22,880
| New | +$9.36M | 1.21% | 6 |
|
2018
Q1 | – | Sell |
-22,855
| Closed | -$4.28M | – | 428 |
|
2017
Q4 | $4.28M | Buy |
22,855
+18
| +0.1% | +$3.37K | 0.61% | 35 |
|
2017
Q3 | $3.85M | Buy |
22,837
+93
| +0.4% | +$15.7K | 0.62% | 39 |
|
2017
Q2 | $3.26M | Buy |
22,744
+2,705
| +13% | +$388K | 0.61% | 40 |
|
2017
Q1 | $2.51M | Buy |
20,039
+10,331
| +106% | +$1.29M | 0.55% | 47 |
|
2016
Q4 | $1.09M | Buy |
9,708
+157
| +2% | +$17.7K | 0.28% | 126 |
|
2016
Q3 | $1.23M | Sell |
9,551
-177
| -2% | -$22.8K | 0.33% | 102 |
|
2016
Q2 | $1.06M | Buy |
+9,728
| New | +$1.06M | 0.32% | 110 |
|